Home › NDC Lookup › RxCUI directory › RxCUI 403807

Pegvisomant 15 MG Injection — RxCUI 403807

RxNorm drug concept · Semantic clinical drug
RxCUI 403807 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI403807
Official namePegvisomant 15 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped10
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegvisomant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acromegaly happens when your body makes too much growth hormone for too long — it can cause bones, hands, feet, and facial features to enlarge, and it raises the risk of other heal...
  • What exactly is acromegaly, and why do I need this medication?
  • Before you start injecting at home, your healthcare team will train you on the technique. Each day, you'll mix the powder with the provided sterile water, swirl gently (never shake...
  • How do I give myself this injection at home?
📖 Read our full Pegvisomant guide →

🕸️ Concept Web — How Pegvisomant 15 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pegvisomant 15 MG Injection RxCUI 403807

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pegvisomant 278739
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Somavert 356771
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pegvisomant Injection 1791293
    • Pegvisomant Injectable Product 1161383
    • Pegvisomant Injection [Somavert] 1791296
    • Somavert Injectable Product 1185416
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pegvisomant 15 MG SCDC · 1791298
  • Pegvisomant Injection SCDF · 1791293
  • Pegvisomant Injectable Product SCDG · 1161383

Brand-Name Concepts

  • Pegvisomant 15 MG Injection [Somavert] SBD · 404458
  • Pegvisomant 15 MG [Somavert] SBDC · 1791300
  • Pegvisomant Injection [Somavert] SBDF · 1791296
  • Somavert Injectable Product SBDG · 1185416
  • Somavert BN · 356771

📦 FDA Products & Package NDCs

5 products · 10 package NDCs
10 package NDCs map to RxCUI 403807 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-7166-01 1 KIT in 1 CARTON (0009-7166-01) * 1 mL in 1 VIAL, SINGLE-... SOMAVERT Pharmacia & Upjohn Company LLC 2016-10-01
00009-7166-30 30 KIT in 1 CARTON (0009-7166-30) / 1 KIT in 1 KIT * 1 mL... SOMAVERT Pharmacia & Upjohn Company LLC 2022-01-17
00009-7168-01 1 KIT in 1 CARTON (0009-7168-01) * 1 mL in 1 VIAL, SINGLE-... SOMAVERT Pharmacia & Upjohn Company LLC 2016-10-01
00009-7168-30 30 KIT in 1 CARTON (0009-7168-30) / 1 KIT in 1 KIT * 1 mL... SOMAVERT Pharmacia & Upjohn Company LLC 2022-01-17
00009-7188-01 1 KIT in 1 CARTON (0009-7188-01) * 1 mL in 1 VIAL, SINGLE-... SOMAVERT Pharmacia & Upjohn Company LLC 2016-10-01
00009-7188-30 30 KIT in 1 CARTON (0009-7188-30) / 1 KIT in 1 KIT * 1 mL... SOMAVERT Pharmacia & Upjohn Company LLC 2022-01-17
00009-7199-01 1 KIT in 1 CARTON (0009-7199-01) * 1 mL in 1 SYRINGE (0009... SOMAVERT Pharmacia & Upjohn Company LLC 2016-10-01
00009-7199-30 30 KIT in 1 CARTON (0009-7199-30) / 1 KIT in 1 KIT * 1 mL... SOMAVERT Pharmacia & Upjohn Company LLC 2022-01-17
00009-7200-01 1 KIT in 1 CARTON (0009-7200-01) * 1 mL in 1 VIAL, SINGLE-... SOMAVERT Pharmacia & Upjohn Company LLC 2016-10-01
00009-7200-30 30 KIT in 1 CARTON (0009-7200-30) / 1 KIT in 1 KIT * 1 mL... SOMAVERT Pharmacia & Upjohn Company LLC 2022-01-17
Observed labelers: Pharmacia & Upjohn Company LLC (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.